Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19
Clinical trial NCT04385186 · UNKNOWN
Trial details
- NCT number
- NCT04385186
- Sponsor
- National Blood Center Foundation, Hemolife
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-20
- Primary completion
- 2020-11-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.